Journal ArticleAnn Surg Oncol · April 2025
BACKGROUND: Randomized data suggest improved survival with adjuvant chemotherapy for biliary tract cancers; however, subset analyses of intrahepatic cholangiocarcinoma (IHC) show limited survival benefit. This study evaluated the impact of adjuvant chemoth ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 27, 2025
BACKGROUND: Adjuvant therapies reduce recurrence in patients with clinical stage IIB/IIC/III melanoma; however, better risk stratification and patient selection are needed. Circulating tumor DNA (ctDNA) as a marker of micrometastatic residual disease is be ...
Full textLink to itemCite